6 million people? Each bought ONE share? Is this the same logic you use to conclude bavi works?
The article brought a good point on 1st line NSCLC. IMO, based on supposed mechanism of action of bavi, if it doesn't work in 1st line NSCLC, there is no reason it should work in 2nd line NSCLC. Instead of waiting OS data from 2nd line, should look for 1st line OS data.
Seems like fair points to me.
So since the two trials were done with two different chemo agents are you saying that all chem agents affect the PS the same?